BlackRock Health Sciences Trust (NYSE:BME) Share Price Breaks Below 50 Day Moving Average – Here’s What Happened

BlackRock Health Sciences Trust (NYSE:BME – Get Free Report)’s share price passed below its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $44.37 and traded as low as $44.24. BlackRock Health Sciences Trust shares last traded at $44.9780, with a volume of 41,352 shares trading hands.

BlackRock Health Sciences Trust Stock Performance

The company has a fifty day moving average of $44.47 and a two-hundred day moving average of $41.66.

BlackRock Health Sciences Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, December 22nd. Investors of record on Friday, December 11th will be given a dividend of $0.2621 per share. The ex-dividend date of this dividend is Friday, December 11th. This represents a $3.15 annualized dividend and a yield of 7.0%.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Bank of America Corp DE bought a new position in BlackRock Health Sciences Trust in the second quarter valued at approximately $11,827,000. 1607 Capital Partners LLC raised its position in BlackRock Health Sciences Trust by 49.5% during the fourth quarter. 1607 Capital Partners LLC now owns 229,260 shares of the company’s stock valued at $9,429,000 after purchasing an additional 75,958 shares in the last quarter. Cypress Capital Management LLC WY lifted its stake in BlackRock Health Sciences Trust by 18.8% during the second quarter. Cypress Capital Management LLC WY now owns 53,307 shares of the company’s stock worth $2,290,000 after purchasing an additional 8,447 shares during the last quarter. Wealthspire Retirement LLC lifted its stake in BlackRock Health Sciences Trust by 12.2% during the first quarter. Wealthspire Retirement LLC now owns 51,887 shares of the company’s stock worth $1,998,000 after purchasing an additional 5,635 shares during the last quarter. Finally, First Trust Advisors LP boosted its holdings in shares of BlackRock Health Sciences Trust by 16.5% in the 1st quarter. First Trust Advisors LP now owns 26,507 shares of the company’s stock valued at $1,021,000 after purchasing an additional 3,745 shares in the last quarter.

BlackRock Health Sciences Trust Company Profile

(Get Free Report)

BlackRock Health Sciences Trust (NYSE:BME) is a closed-end investment company focused on the global health sciences sector. The fund seeks to provide investors with total return through a combination of current income and capital appreciation by investing primarily in the equity securities of companies involved in health care and related industries.

Its portfolio may include companies engaged in pharmaceuticals, biotechnology, medical devices, health care services, diagnostics, and other areas supporting the development and delivery of health-related products and services.

Featured Articles

Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.